Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2014 Apr;58(4):2489. doi: 10.1128/AAC.00134-14

Pharmacodynamics of a New Cephalosporin, PPI-0903 (TAK-599), Active against Methicillin-Resistant Staphylococcus aureus in Murine Thigh and Lung Infection Models: Identification of an In Vivo Pharmacokinetic-Pharmacodynamic Target

D Andes 1, W A Craig 1
PMCID: PMC4023747

AUTHOR CORRECTION

Volume 50, no. 4, p 1376–1383, 2006. Page 1376: Abstract, line 18, should read “Mean free-drug %T>MICs ± the standard deviation associated with the static effect endpoint for S. pneumoniae, S. aureus, and gram-negative isolates were 39 ± 9, 26 ± 8, and 47 ± 8, respectively.”

Page 1380: Table 3 should appear as shown below, with corrected MIC values for the bottom third of the table.

TABLE 3.

PPP-0903 in vivo activity in murine thigh and lung infection models against multiple organisms

Organism MIC (mg/liter) Static
1 log kill
2 log kill
Dose (mg/kg/24 h) %T>MIC Dose (mg/kg/24 h) %T>MIC Dose (mg/kg/24 h) %T>MIC
S. pneumoniae 10813 (neutropenic) 0.008 0.32 34 0.45 37 0.61 43
S. pneumoniae 10813 (normal) 0.20 29 0.29 33 0.41 36
S. pneumoniae 1199 0.06 1.8 35 3.42 44 6.03 51
S. pneumoniae 1329 0.06 1.15 30 2.04 37 3.72 45
S. pneumoniae 1325 0.06 6.5 52 8.46 53 10.65 60
S. pneumoniae 1293 0.12 14.3 50 22.2 59 34.0 64
Mean ± SD 39 ± 9 43 ± 9 50 ± 10
S. aureus 25923 0.12 3.75 36 7.23 44 14.8 51
S. aureus 29213 0.25 2.57 30 7.63 37 26.9 56
MRSA 0.50 9.88 21 22.0 34 64.1 50
S. aureus 33591 1.0 6.19 15 9.98 18 18.0 23
Mean ± SD 26 ± 8 33 ± 9 45 ± 13
E. coli 25922 0.125 5.64 36 8.92 41 15.4 48
E. coli 1894-1 0.125 23.4 54 104 88 >160
K. pneumoniae 43816 (thigh) 0.125 21.6 53 51.5 74 >400
K. pneumoniae 43816 (lung) 37.6 64 124 91 >400
K. pneumoniae 216 0.125 12.5 45 53.2 75 >160
Mean ± SD 47 ± 8 69 ± 20

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES